Restrictions could be lifted on peptides loved by wellness influencers
NPR's reporting includes an interview with attorney Lee Rosebush, who represents peptide manufacturers and sued the FDA over its 2023 compounding restrictions, arguing that removing pharmacy access simply pushed consumers toward unregulated gray- and black-market sellers rather than improving safety.
This is a summary. The reporting is NPR's, and the link below goes to the original article.